|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's range||5.0000 - 5.0000|
|52-week range||0.1000 - 2,844.0000|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||0.04|
|Earnings date||27 Apr 2020 - 01 May 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||54.44|
Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of a deadline to file a lead plaintiff motion in a securities class action has been filed on behalf of investors that purchased or acquired the securities of NMC Health PLC ("NMC Health" or the "Company") ( OTC BB: NMHLY) between March 13, 2016 and March 10, 2020 (the "Class Period"). The lawsuit filed in the United States District Court for the Central District of California alleges violations of the Securities Exchange Act of 1934.
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of NMC Health Plc (OTC: NMHLY) between March 13, 2016 and March 10, 2020, inclusive (the "Class Period"), of the important May 11, 2020 lead plaintiff deadline in the securities class action first filed by the firm. The lawsuit seeks to recover damages for NMC investors under the federal securities laws.
Shareholder rights law firm Robbins LLP announces that it is investigating NMC Health Plc (OTC: NMHLY) for alleged violations of the Securities Exchange Act of 1934 and whether the Company's officers and directors breached their fiduciary duties to shareholders. NMC provides healthcare services in the United Arab Emirates, the United Kingdom, Spain, and internationally.